Global Tissue Engineering Market to Reach $26.8 Billion by 2027

12 Mar 2021
www.globenewswire.com
Collaborate
New York, March 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tissue Engineering Industry" - In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack. - Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations. Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments. Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments. Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience. Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience. Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics. for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics. Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations. Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations. Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives. Abstract: - Global Tissue Engineering Market to Reach $26.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Tissue Engineering estimated at US$11 Billion in the year 2020, is projected to reach a revised size of US$26.8 Billion by 2027, growing at a CAGR of 13.5% over the analysis period 2020-2027. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is projected to record a 12.1% CAGR and reach US$6.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cardiology & Vascular segment is readjusted to a revised 15.7% CAGR for the next 7-year period. - The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 13.1% CAGR - The Tissue Engineering market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2027 trailing a CAGR of 13.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.7% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR. - Cord Blood & Cell Banking Segment to Record 14.7% CAGR - In the global Cord Blood & Cell Banking segment, USA, Canada, Japan, China and Europe will drive the 14.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.2 Billion by the year 2027. Select Competitors (Total 33 Featured) - Acelity L.P. Inc. Advanced Cell Technology Allergan Plc Arteriocyte Athersys Baxter International Inc BioMimetic Therapeutics Cook Biotech Inc. CryoLife DePuy Synthes (Johnson & Johnson Services, Inc.) Integra Life Sciences Corporation LifeCell Kinetic Concepts Medtronic Organogenesis Inc. RTI surgical Sanofi StemCells, Inc. Stryker Corporation Zimmer Biomet Read the full report: I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession Global Competitor Market Shares Tissue Engineering Competitor Market Share Scenario Worldwide (in %): 2020E Global Competitor Market Shares by Segment 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 2: World 7-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 Table 3: World Current & Future Analysis for Orthopedics, Musculoskeletal & Spine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 4: World 7-Year Perspective for Orthopedics, Musculoskeletal & Spine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 5: World Current & Future Analysis for Cardiology & Vascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 6: World 7-Year Perspective for Cardiology & Vascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 7: World Current & Future Analysis for Cord Blood & Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 8: World 7-Year Perspective for Cord Blood & Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 9: World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 10: World 7-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 11: World Current & Future Analysis for Gastrointestinal & Gynecology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 12: World 7-Year Perspective for Gastrointestinal & Gynecology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 13: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 14: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Market Facts & Figures Market Analytics Table 15: USA Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 16: USA 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 CANADA Table 17: Canada Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 18: Canada 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 JAPAN Table 19: Japan Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 20: Japan 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 CHINA Table 21: China Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 22: China 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 EUROPE Market Facts & Figures Market Analytics Table 23: Europe Current & Future Analysis for Tissue Engineering by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 24: Europe 7-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 Table 25: Europe Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 26: Europe 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 FRANCE Table 27: France Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 28: France 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 GERMANY Table 29: Germany Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 30: Germany 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 ITALY Table 31: Italy Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 32: Italy 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 UNITED KINGDOM Table 33: UK Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 34: UK 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 REST OF EUROPE Table 35: Rest of Europe Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 36: Rest of Europe 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 ASIA-PACIFIC Table 37: Asia-Pacific Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 38: Asia-Pacific 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 REST OF WORLD Table 39: Rest of World Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 40: Rest of World 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 IV. COMPETITION Total Companies Profiled: 33 Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.